Berotralstat dihydrochloride (Standard)

Overview

Berotralstat dihydrochloride (Standard) is the analytical standard of Berotralstat (dihydrochloride) ( HY-109127A ). This product is intended for research and analytical applications. Berotralstat dihydrochloride (BCX7353 dihydrochloride) is an orally active plasma kallikrein inhibitor . Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema.

Application

Products | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Others | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Kallikrein | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-109127AR
• CAS No.: 1809010-52-3
• Molecular Formula: C30H28Cl2F4N6O
• Molecular Weight: 635.48
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source